Current treatment strategy of diffuse large B-cell lymphomas

International Journal of Hematology

Volumn 92, Issue 2, 2010, Pages 231-237

  Niitsu, Nozomi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

DLBCL; R CHOP; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE FREE SURVIVAL; DRUG MECHANISM; HUMAN; LARGE CELL LYMPHOMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; REVIEW; TREATMENT PLANNING;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE;

EID: 77956909889     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0666-x     Document Type: Review

References (24)

1. RI Fisher ER Gaynor S Dahlberg MM Oken TM Grogan EM Mize, et al. 1993 Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Engl J Med 328 1002 1006 1:STN:280:DyaK3s7ps1Kmtg%3D%3D 10.1056/NEJM199304083281404 7680764 (Pubitemid 23095683)
2. TP Miller S Dahlberg JR Cassady DJ Adelstein CM Spier TM Grogan 1998 Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma N Engl J Med 339 21 26 1:STN:280:DyaK1c3pvFersA%3D%3D 10.1056/NEJM199807023390104 9647875 (Pubitemid 28304493)
3. TP Miller M LeBlanc C Spier, et al. 2001 CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial Blood 98 724a 725a 10.1182/blood.V98.3.705
4. SJ Horning E Weller K Kim JD Earle MJ O'Connell TM Habermann, et al. 2004 Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484 J Clin Oncol 22 3032 3038 1:CAS:528:DC%2BD2cXpsVGku78%3D 10.1200/JCO.2004.06.088 15210738 (Pubitemid 41103714)
5. C Bonnet G Fillet N Mounier G Ganem TJ Molina C Thiéblemont, et al. 2007 Groupe d'Etude des Lymphomes de l'Adulte. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 25 787 792 1:CAS:528:DC%2BD2sXjvVKmt7Y%3D 10.1200/JCO.2006.07.0722 17228021 (Pubitemid 350002878)
6. F Reyes E Lepage G Ganem TJ Molina P Brice B Coiffier, et al. 2005 Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma N Engl J Med. 352 1197 1205 1:CAS:528:DC%2BD2MXisFSht7k%3D 10.1056/NEJMoa042040 15788496 (Pubitemid 40397261)
7. DO Persky JM Unger CM Spier B Stea M LeBlanc MJ McCarty, et al. 2008 Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014 J Clin Oncol 26 2258 2263 1:CAS:528:DC%2BD1cXntVOltrw%3D 10.1200/JCO.2007.13.6929 18413640
8. Pfreundschuh M, Trümper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;5:379-91.
9. ME Reff K Carner KS Chambers PC Chinn JE Leonard R Raab, et al. 1994 Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 83 435 445 1:CAS:528:DyaK2cXhtVCnu70%3D 7506951
10. G Cartron L Dacheux G Salles P Solal-Celigny P Bardos P Colombat, et al. 2002 Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene Blood 99 754 758 1:CAS:528:DC%2BD38XhtVals7k%3D 10.1182/blood.V99.3.754 11806974 (Pubitemid 34525533)
11. L Elias CS Portlock SA Rosenberg 1978 Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) Cancer 42 1705 1710 1:STN:280:DyaE1M%2FktlGjtA%3D%3D 10.1002/1097-0142(197810)42:4<1705::AID-CNCR2820420408>3.0.CO;2-P 361209
12. P Klimo JM Connors 1985 MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma Ann Intern Med 102 596 602 1:STN:280:DyaL2M7nt12iug%3D%3D 2580468
13. DL Longo VT DeVita Jr PL Duffey MN Wesley DC Ihde SM Hubbard, et al. 1991 Superiority of Pro-MACE-CytaBOM over Pro-MACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized study J Clin Oncol 9 25 38 1:STN:280:DyaK3M%2Fos12lsw%3D%3D 1702144
14. MA Shipp 1993 International non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 987 994 10.1056/NEJM199309303291402 (Pubitemid 23307906)
15. B Coiffier E Lepage J Briere R Herbrecht H Tilly R Bouabdallah, et al. 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235 242 1:CAS:528:DC%2BD38XmslGgsw%3D%3D 10.1056/NEJMoa011795 11807147 (Pubitemid 34438862)
16. P Feugier A Van Hoof C Sebban P Solal-Celigny R Bouabdallah C Fermé, et al. 2005 Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 23 4117 4126 1:CAS:528: DC%2BD2MXmt1elsr0%3D 10.1200/JCO.2005.09.131 15867204 (Pubitemid 46211317)
17. M Pfreundschuh J Schubert M Ziepert R Schmits M Mohren E Lengfelder, et al. 2008 Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol 9 105 116 1:CAS:528: DC%2BD1cXhsVOnu7g%3D 10.1016/S1470-2045(08)70002-0 18226581
18. TM Habermann EA Weller VA Morrison RD Gascoyne PA Cassileth JB Cohn, et al. 2006 Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 24 3121 3127 1:CAS:528:DC%2BD28XnslKhsL4%3D 10.1200/JCO.2005.05.1003 16754935 (Pubitemid 46638950)
19. H Tilly E Lepage B Coiffier M Blanc R Herbrecht A Bosly, et al. 2003 Groupe d'Etude des Lymphomes de l'Adulte. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Blood 102 4284 4289 1:CAS:528:DC%2BD3sXpslGrsrg%3D 10.1182/blood-2003-02-0542 12920037 (Pubitemid 37494085)
20. M Pfreundschuh L Trumper M Kloess R Schmits AC Feller C Rübe, et al. 2004 Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL Blood 104 626 633 1:CAS:528:DC%2BD2cXmtlCkt7k%3D 10.1182/blood-2003-06-2094 14982884 (Pubitemid 38970553)
21. Niitsu N, Kohri M, Hagiwara Y, Tanae K, Takahashi N, Bessho M, et al. Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma. Hematol Oncol. 2010 Mar 17 [Epub ahead of print].
22. A Greb J Bohlius S Trelle D Schiefer CA De Souza C Gisselbrecht, et al. 2007 High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma-results of a comprehensive meta-analysis Cancer Treat Rev 33 338 346 1:CAS:528:DC%2BD2sXlsF2rsbk%3D 10.1016/j.ctrv.2007.02.002 17400393 (Pubitemid 46778207)
23. G Barosi AM Carella M Lazzarino M Marchetti M Martelli A Rambaldi, et al. 2006 Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation Haematologica 91 96 103 16434377 (Pubitemid 43235392)
24. N Niitsu M Okamoto I Miura M Hirano 2009 Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations Leukemia 23 777 783 1:CAS:528:DC%2BD1MXks1Sitbg%3D 10.1038/leu.2008.344 19151788